Towards improved respiratory outcomes in preterm infants through rapid and effective aerosalisation of medication to the lung

通过快速有效地将药物气雾化至肺部，改善早产儿的呼吸结果

• 批准号: nhmrc : 1123030
• 金额: $ 17.4万
• 依托单位: Murdoch Childrens Research Institute
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improved-respiratory-outcomes-medication-lung/947080
• 关键词: Towards; improved; respiratory; outcomes; preterm

Babies born premature are greatest at risk from increasingly common respiratory illnesses. It is possible that delivering a medication by aerosol will be the most effective method of treatment. For premature babies that need breathing support, inhaled medication could improve care. For highly infectious respiratory illnesses such as RSV, with no vaccines available, we need to protect babies very early in life. I will use an established lamb model to test fast medication delivery to the lungs.

早产儿患日益常见的呼吸系统疾病的风险最大。用气雾剂给药可能是最有效的治疗方法。对于需要呼吸支持的早产儿，吸入药物可以改善护理。对于高度传染性的呼吸道疾病，如呼吸道合胞病毒，由于没有可用的疫苗，我们需要在生命的早期就保护婴儿。我将使用已建立的羔羊模型来测试药物快速输送到肺部。